Related content

QSAR of Human Factor Xa Inhibitor N2-Aroylanthranilamides Using Principal Component Factor Analysis

By Roy Kunal   De A. U.   Sengupta Chandana  

Drug Design and Discovery, Vol. 18, Iss. 1, 2002-03 ,pp. : 23-31

Taylor & Francis Ltd

Access to resources Recommend Favorite

Using principal component analysis in studying the transdermal delivery of a lipophilic drug from soft nano-colloidal carriers to develop a quantitative composition effect permeability relationship

By Hathout Rania M.  

Pharmaceutical Development and Technology, Vol. 19, Iss. 5, 2014-08 ,pp. : 598-604

Informa Healthcare

Access to resources Recommend Favorite

The Influence of Lipophilicity on the Classification of Antitumor Acridinones Evaluated by Principal Component Analysis

By  

Current Pharmaceutical Analysis, Vol. 8, Iss. 2, 2012-01 ,pp. : 157-174

Bentham Science Publishers

Access to resources Recommend Favorite

Features of the principal component analysis for the classification of biologically active compounds in terms of molecular descriptors

By Kabankin A.   Gabrielyan L.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 6, 2006-06 ,pp. : 307-311

Springer Publishing Company

Access to resources Recommend Favorite

Design and Development of Microemulsion Based Transdermal Gel of Lercanidipine Hydrochloride by Assimilation of Rotatable Central Composite Design and Principal Component Analysis

By  

Pharmaceutical Nanotechnology, Vol. 1, Iss. 4, 2013-11 ,pp. : 290-305

Bentham Science Publishers

Access to resources Recommend Favorite